​

Fulcrum Therapeutics Ownership | Who Owns Fulcrum Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

Fulcrum Therapeutics Ownership Summary

Fulcrum Therapeutics is owned by 87.76% institutional investors, 1.62% insiders, and 10.62% retail investors. Ra capital management is the largest institutional shareholder, holding 18.73% of FULC shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.43% of its assets in Fulcrum Therapeutics shares.

FULC Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockFulcrum Therapeutics87.76%1.62%10.62%
SectorHealthcare Stocks 88.01%8.90%3.09%
IndustryBiotech Stocks 109.70%8.77%-18.47%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Ra capital management11.61M18.73%$71.98M
Fmr5.33M8.60%$33.05M
Blackrock4.80M7.74%$29.75M
Vanguard group3.07M4.95%$19.04M
Suvretta capital management2.54M4.10%$15.75M
Trv gp iv2.34M3.78%$14.53M
Logos global management lp1.50M2.42%$9.30M
Dimensional fund advisors lp1.48M2.39%$9.18M
Geode capital management1.31M2.11%$8.11M
Morgan stanley1.23M1.99%$7.66M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Trv gp iv2.34M7.18%$14.53M
Mass general brigham205.36K6.20%$1.27M
Ra capital management11.61M0.95%$71.98M
Logos global management lp1.50M0.75%$9.30M
Suvretta capital management2.54M0.58%$15.75M
Matisse capital128.44K0.31%$603.69K
Simplify asset management674.83K0.28%$4.18M
Corton capital26.17K0.09%$162.27K
Gsa capital partners llp135.22K0.06%$838.00K
Sphera funds management59.00K0.05%$365.80K

Top Buyers

HolderShares% AssetsChange
Blackrock4.80M0.00%3.26M
State street1.04M0.00%784.41K
Geode capital management1.31M0.00%743.92K
Vanguard group3.07M0.00%532.48K
Woodline partners lp501.30K0.03%501.30K

Top Sellers

HolderShares% AssetsChange
Rtw investments, lp---5.85M
Cowen and company---2.96M
Bioimpact capital---1.44M
Jefferies financial group---1.43M
Vestal point capital, lp---1.16M

New Positions

HolderShares% AssetsChangeValue
Woodline partners lp501.30K0.03%501.30K$3.11M
Nuveen asset management169.55K0.00%169.55K$1.05M
Sphera funds management59.00K0.05%59.00K$365.80K
Corebridge financial33.38K0.00%33.38K$207.31K
Prelude capital management28.10K0.01%28.10K$174.22K

Sold Out

HolderChange
Daiwa securities group-138.00
Gamma investing-198.00
Quadrant capital group-1.04K
Mirae asset global investments-2.26K
Bfsg-2.51K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20241499.56%54,770,426-15.49%870.80%77-2.53%3529.63%
Jun 30, 20241360.74%64,812,4127.35%1041.08%799.72%27-3.57%
Mar 31, 202413531.07%60,375,967-0.73%981.02%7241.18%2827.27%
Dec 31, 202310321.18%60,818,5207.84%981.18%5145.71%22-12.00%
Sep 30, 202385-6.59%56,394,5921.60%911.06%35-10.26%25-21.88%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.85M3.43%-
iShares Russell 2000 ETF1.70M3.15%-6.53K
Fidelity Growth Compy Commingled Pl O1.35M2.16%-464.60K
Fidelity Select Biotechnology1.14M1.83%-111.80K
Fidelity Small Cap Index636.02K1.18%-455.00
Fidelity Select Pharmaceuticals Port683.60K1.10%-
Vanguard Institutional Extnd Mkt Idx Tr583.96K1.08%-198.51K
Fidelity Growth Compy Commingled Pl S494.64K0.92%-295.57K
SPDR® S&P Pharmaceuticals ETF436.70K0.81%-
Candriam Eqs L Biotech C USD Cap474.70K0.76%474.70K

Recent Insider Transactions

DateNameRoleActivityValue
May 07, 2024Tourangeau Greg Principal Accounting OfficerSell$1.83K
Mar 08, 2024Tourangeau Greg Vice President, FinanceSell$57.22K
Mar 04, 2024Sapir Alex See RemarksBuy$492.03K
May 10, 2023Tourangeau Greg Principal Accounting OfficerSell$695.10
Jan 20, 2023RA CAPITAL MANAGEMENT, L.P.-Buy$25.00M

Insider Transactions Trends

DateBuySell
2024 Q4--
2024 Q3--
2024 Q2-1
2024 Q111
2023 Q3--

FULC Ownership FAQ

Who Owns Fulcrum Therapeutics?

Fulcrum Therapeutics shareholders are primarily institutional investors at 87.76%, followed by 1.62% insiders and 10.62% retail investors. The average institutional ownership in Fulcrum Therapeutics's industry, Biotech Stocks , is 109.70%, which Fulcrum Therapeutics falls below.

Who owns the most shares of Fulcrum Therapeutics?

Fulcrum Therapeutics’s largest shareholders are Ra capital management (11.61M shares, 18.73%), Fmr (5.33M shares, 8.60%), and Blackrock (4.8M shares, 7.74%). Together, they hold 35.07% of Fulcrum Therapeutics’s total shares outstanding.

Does Blackrock own Fulcrum Therapeutics?

Yes, BlackRock owns 7.74% of Fulcrum Therapeutics, totaling 4.8M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 29.75M$. In the last quarter, BlackRock increased its holdings by 3.26M shares, a 211.35% change.

Who is Fulcrum Therapeutics’s biggest shareholder by percentage of total assets invested?

Trv gp iv is Fulcrum Therapeutics’s biggest shareholder by percentage of total assets invested, with 7.18% of its assets in 2.34M Fulcrum Therapeutics shares, valued at 14.53M$.

Who is the top mutual fund holder of Fulcrum Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Fulcrum Therapeutics shares, with 3.43% of its total shares outstanding invested in 1.85M Fulcrum Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools